The two major families of kinases in the Hippo pathway, MST1/2 and LATS1/2, may also be promising therapeutic targets for MM, owing to their role in directing the phosphorylation and cytoplasmic sequestration of YAP1/TAZ. This evidence concerns the gene YAP1 and Miyoshi myopathy.